Sehyo Yune, MD
,
Department of Medicine, Samsung Medical Center, Seoul, South Korea
Jin-Young Lee, MD, PhD
,
Health Promotion Center, Samsung Medical Center, Seoul, South Korea
Jihye Kim, MD
,
Department of Medicine, Samsung Medical Center, Seoul, South Korea
Young Nam Kim, MD
,
Department of Medicine, Samsung Medical Center, Seoul, South Korea
Young Eun Kim
,
Department of Pharmacy, Samsung Medical Center, Seoul, South Korea
Yongseok Lee
,
Department of Pharmacy, Samsung Medical Center, Seoul, South Korea
Jae-Won Paeng
,
Samsung Biomedical Research Institute, Seoul, South Korea
Mi-Jin Jang
,
Samsung Biomedical Research Institute, Seoul, South Korea
Dong-Chull Choi, MD, PhD
,
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Byung-Jae Lee, MD, PhD
,
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Drug-induced anaphylaxis is a big pitfall in patients receiving antineoplastic chemotherapy. We report a case of lung cancer patient who experienced two near-fatal anaphylactic reactions that resulted from paclitaxel and multivitamin, separately. Recurrent severe reactions to different agents led to further investigation to which material the patient was hypersensitive. The skin prick test revealed sensitization to cremophor, which is a commonly used emulsifying agent. This case emphasizes the importance of correctly identifying the culprit drug of anaphylaxis to avoid potentially fatal reaction.